期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022; 31 (1)
Background: Hepatocellular carcinoma (HCC) is frequently diagnosed at late stages when curative treatments are no more appliable. Many studies have pr......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022; 31 (2)
Aim: To investigate the efficacy of postoperative adjuvant transarterial chemoembolization (TACE) in patients with intrahepatic cholangiocarcinoma (IC......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022; 31 (1)
Background & Aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed to replace the concept of non-alcoholic fatty li......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022; 31 (3)
Aims: To compare the efficacy, safety, and survival outcomes of hepatic arterial infusion chemotherapy (HAIC) versus transarterial chemoembolization (......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022; 31 (1)
Background & Aims: 'the effect of linked color imaging (LCI) compared with white light imaging (WLI) is conflicting. The aim of this meta-analysis......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (3)
Background & Aims: Patients with inflammatory bowel diseases (IBD) are at high risk of developing several autoimmune diseases. However, the epidem......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (4)
Background & Aims: TUBA1A belongs to the tubulin superfamily, and its role in gastric cancer (GC) remains unclear. This study assessed the express......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (2)
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) prevalence has increased in the past two decades, resulting in a sign......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (2)
Aims: Comparing the risk of abnormal liver function tests between severe and non-severe patients with coronavirus disease 2019 (COVID-19) by meta-anal......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (2)
Background and aims: Multiple pharmacologic treatments are available for the management of irritable bowel syndrome (IBS), and a large body of evidenc......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (1)
Eosinophilic esophagitis (EoE) is an eosinophil-rich, Th2 antigen-mediated disease of increasing worldwide prevalence. Originally considered common in......
期刊： JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020; 29 (1)
Background & Aims: Studies on the association between homocysteine and non-alcoholic fatty liver disease (NAFLD) have shown inconsistent results. ......
